Please assess the completion status of the following clinical trial:

Trial Title: Early Versus Late Use of Ibuprofen for Patent Ductus Arteriosus (PDA) Closure

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Birth weight less than 1200gm~* Less than 28 weeks gestational age~* Confirmed Patent Ductus Arteriosus (PDA) via echocardiogram and clinical exam~Exclusion Criteria:~* Active Bleeding~* Currently being treated for Persistent Pulmonary Hypertension (PPHN)~* Cardiac anomalies~* Chromosomal abnormalities~* Endocrine, metabolic, renal, or hepatic disorders

- Gender: ALL
- Minimum Age: None
- Maximum Age: 96 Hours
- Healthy Volunteers: f

Study Arms:
- Early treatment (Type: ACTIVE_COMPARATOR): Infants randomized to this group will receive their initial dose of ibuprofen prior to reaching 96 hrs old
- Late treatment (Type: ACTIVE_COMPARATOR): Infants randomized to this group will receive their initial dose of ibuprofen after infant has reached 96 hrs old but before the infant reaches 10 days old.

Based on this trial design, predict the completion outcome and termination type (if applicable).